Cargando…
S231: PRIMARY MEDIASTINAL B-CELL LYMPHOMA HAVE A SUPERIOR OUTCOME COMPARED TO DIFFUSE LARGE-B-CELL LYMPHOMA TREATED WITH AXICABTAGENE CILOLEUCEL IN THE CART-SIE REAL LIFE ITALIAN STUDY
Autores principales: | Chiappella, Annalisa, Dodero, Anna, Guidetti, Anna, Ljevar, Silva, Pennisi, Martina, Casadei, Beatrice, Galli, Eugenio, Rocco, Alice DI, Cutini, Ilaria, Barbui, Anna Maria, Bramanti, Stefania, Musso, Maurizio, Tisi, Maria Chiara, Carrabba, Matteo Giovanni, Martino, Massimo, Farina, Mirko, Botto, Barbara, Grillo, Giovanni, Ladetto, Marco, Olivieri, Jacopo, Arcaini, Luca, Bermema, Anisa, Miceli, Rosalba, Chiusolo, Patrizia, Zinzani, Pier Luigi, Corradini, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428488/ http://dx.doi.org/10.1097/01.HS9.0000967836.08625.7c |
Ejemplares similares
-
P1081: A MULTICENTER OBSERVATIONAL STUDY ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR LARGE B-CELL (LBCL) AND MANTLE CELL (MCL) LYMPHOMAS: THE ITALIAN CART-SIE REAL LIFE EXPERIENCE
por: Chiappella, Annalisa, et al.
Publicado: (2023) -
S228: POSITRON EMISSION TOMOGRAPHY EVALUATION IN A LARGE GROUP OF PATIENTS AFFECTED BY RELAPSED/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY (CART SIE).
por: Dodero, Anna, et al.
Publicado: (2023) -
Axicabtagene ciloleucel for B-cell lymphoma
Publicado: (2021) -
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
por: Kwon, Mi, et al.
Publicado: (2022) -
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
por: Riedell, Peter A., et al.
Publicado: (2020)